SOCIETAL CDMO INC (SCTL) Stock Overview
NASDAQ:SCTL - US75629F1093 - Common Stock
SCTL Key Statistics, Chart & Performance
The current stock price of SCTL is 1.1 USD. In the past month the price increased by 3.77%. In the past year, price increased by 2.8%.
SCTL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 45.29 | 692.20B | ||
| JNJ | JOHNSON & JOHNSON | 17.65 | 425.14B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.4 | 250.17B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.98 | 247.45B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.29 | 244.79B | ||
| MRK | MERCK & CO. INC. | 10.89 | 209.49B | ||
| PFE | PFIZER INC | 7.29 | 140.58B | ||
| SNY | SANOFI-ADR | 11.22 | 121.26B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.97 | 95.53B | ||
| GSK | GSK PLC-SPON ADR | 8.72 | 79.59B | ||
| ZTS | ZOETIS INC | 25.07 | 69.11B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 49.95 | 47.33B |
Related stock screener links
About SCTL
Company Profile
Societal CDMO, Inc. is a bi-coastal CDMO with capabilities spanning pre-investigational new drug (IND) development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a focus on small molecules. The company is headquartered in Exton, Pennsylvania and currently employs 275 full-time employees. The company went IPO on 2014-03-07. The firm is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. The company is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The Company’s products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms and facilities to handle highly potent compounds and controlled substances.
Company Info
SOCIETAL CDMO INC
1 E. Uwchlan Ave, Suite 112
Exton PENNSYLVANIA US
Employees: 275
Phone: 17705348239
SOCIETAL CDMO INC / SCTL FAQ
What is the stock price of SOCIETAL CDMO INC today?
The current stock price of SCTL is 1.1 USD. The price increased by 0.92% in the last trading session.
What is the ticker symbol for SOCIETAL CDMO INC stock?
The exchange symbol of SOCIETAL CDMO INC is SCTL and it is listed on the Nasdaq exchange.
On which exchange is SCTL stock listed?
SCTL stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SOCIETAL CDMO INC stock?
10 analysts have analysed SCTL and the average price target is 1.12 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.1. Check the SOCIETAL CDMO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SOCIETAL CDMO INC worth?
SOCIETAL CDMO INC (SCTL) has a market capitalization of 116.26M USD. This makes SCTL a Micro Cap stock.
How many employees does SOCIETAL CDMO INC have?
SOCIETAL CDMO INC (SCTL) currently has 275 employees.
What are the support and resistance levels for SOCIETAL CDMO INC (SCTL) stock?
SOCIETAL CDMO INC (SCTL) has a support level at 1.07 and a resistance level at 1.1. Check the full technical report for a detailed analysis of SCTL support and resistance levels.
Is SOCIETAL CDMO INC (SCTL) expected to grow?
The Revenue of SOCIETAL CDMO INC (SCTL) is expected to grow by 2.59% in the next year. Check the estimates tab for more information on the SCTL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SOCIETAL CDMO INC (SCTL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SCTL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SCTL, evaluating the profitability, health, valuation and growth aspects
- SOCIETAL CDMO INC (SCTL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SOCIETAL CDMO INC (SCTL) Sales and EPS estimates to see what analysts future expectations are.
- SOCIETAL CDMO INC (SCTL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SOCIETAL CDMO INC (SCTL) Insider and Institutional Ownership to learn about the owners and their transactions.
- SOCIETAL CDMO INC (SCTL) Stock Chart to make your own analysis
- SOCIETAL CDMO INC (SCTL) Latest news and press-releases to stay up to date.
Does SOCIETAL CDMO INC (SCTL) stock pay dividends?
SCTL does not pay a dividend.
When does SOCIETAL CDMO INC (SCTL) report earnings?
SOCIETAL CDMO INC (SCTL) will report earnings on 2024-05-08, after the market close.
What is the Price/Earnings (PE) ratio of SOCIETAL CDMO INC (SCTL)?
SOCIETAL CDMO INC (SCTL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.16).
SCTL Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to SCTL. When comparing the yearly performance of all stocks, SCTL is one of the better performing stocks in the market, outperforming 98.08% of all stocks.
SCTL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SCTL. SCTL may be in some trouble as it scores bad on both profitability and health.
SCTL Financial Highlights
Over the last trailing twelve months SCTL reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS increased by 40.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.64% | ||
| ROE | -22.61% | ||
| Debt/Equity | 0.01 |
SCTL Forecast & Estimates
10 analysts have analysed SCTL and the average price target is 1.12 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.1.
For the next year, analysts expect an EPS growth of 45.81% and a revenue growth 2.59% for SCTL